100 patients enrolled Reduction of falls in overall study population Topline data at the end of Q1'2...
Redeye initiates coverage of MindArk, a Swedish gaming company with a long-standing presence in the ...
Redeye comments on the announcement of sales of the Nevisense device to NIH as a research tool on th...
Redeye comments on Xbrane following today's news that the FDA, like the EMA, has recieved positive f...
The company's third largest shareholder, Rasmussengruppen, have divested its entire holding in Nekka...
Redeye comments on the news that Ngenic and Svea Solar entered a strategic partnership agreement wor...
Redeye comments on the steps in the US to expand the footprint.
Nettoomsättningen uppgick till 49,2 MSEK (48,7) i det första kvartalet (maj-juli) i Purefuns brutna ...
Q3e: sales +17% EBITDA + 39% y-o-y Positive news flow incl.
Redeye embraces the positive results from the SOLARIO trial, and we argue that the company has ticke...
Redeye comments on Iconovo’s announced rights issue of units.
CFO Rasmus Untidt appointed CEO with immediate effect Following past years' restructuring and stream...
Ahead of Fiskars' Q3 report, due on 24 October, we trim our 2024E-26E top line by 1-2% and adjusted ...
Redeye comments on last night's selling from two of Truecaller's largest shareholders (Kleiner Perki...
TCECUR Sweden AB (”TCECUR” eller ”Koncernen”) meddelade den 24 september år 2024 att Jacob Philipsso...
Redeye is encouraged by yesterday’s announcement that Powercell has received another major order fro...
Q3 report due 25 October We forecast SEK 551m net sales, SEK 83m EBITA We reiterate fair value range...
Redeye provides a short comment on Episurf's announcement about the revised estimated timeline for F...
Redeye comments on Arise’s divestment of a 40MW battery project for a total consideration of SEK30m ...
Clean Motion AB utvecklar hållbara transportlösningar för städer, med fokus på att minska koldioxidu...
